Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,574
Closed -$1.86M 477
2026
Q1
$1.86M Hold
24,574
0.05% 278
2025
Q4
$1.83M Hold
24,574
0.05% 289
2025
Q3
$1.66M Buy
24,574
+56
+0.2% +$3.72K 0.04% 280
2025
Q2
$1.6M Hold
24,518
0.05% 285
2025
Q1
$1.48M Sell
24,518
-1,292
-5% -$85.6K 0.05% 297
2024
Q4
$1.86M Buy
+25,810
New +$2.02M 0.06% 260

Other funds holding HOLX

Avanza Fonder's HOLX Position: Q2 2026 in Review

Avanza Fonder sold out of Hologic (HOLX) in Q2 2026, closing a stake of 24,574 shares — an estimated $1.86M sold.

Avanza Fonder first reported a position in HOLX in Q4 2024 and held it in 6 quarters. The position peaked at $1.86M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Avanza Fonder reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Avanza Fonder sold 24,574 Hologic shares in Q2 2026, an estimated $1.86M.
  • Avanza Fonder first reported a position in Hologic in Q4 2024 and held it in 6 quarters.
  • Avanza Fonder's Hologic position peaked at $1.86M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.